Drug: INFLIXIMAB Injury: Condition aggravated Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
114908795 | INFLIXIMAB | Condition aggravated | AMGEN | 3.00 YR | F | 64 KG | 20160719 | CA |
115673566 | INFLIXIMAB | Condition aggravated | ROCHE | 8.00 YR | F | 64 KG | 20160921 | CA |
125349181 | INFLIXIMAB | Condition aggravated | ABBVIE | 35.00 YR | F | 0 | 20160707 | GB |
125621961 | Infliximab | Condition aggravated | MEDAC | 35.00 YR | F | 0 | 20160715 | COUNTRY NOT SPECIFIED |
125757601 | INFLIXIMAB | Condition aggravated | SANDOZ | 35.00 YR | F | 0 | 20160720 | GB |
125790752 | INFLIXIMAB | Condition aggravated | SANDOZ | 73.00 YR | F | 0 | 20160902 | DK |
126050671 | INFLIXIMAB | Condition aggravated | AMGEN | 18.00 YR | F | 0 | 20160728 | CA |
Total Records: 7 Number of Pages: 1